Safety Studies. Avivagen completed a series of safety evaluations based on the oxidized beta-carotene (OxBC), a critical active ingredient in the OxC-beta product line. Results of the Avivagen-initiated toxicology study, conducted following standardized and internationally recognized protocols, provided further evidence of the safety and effectiveness of OxBC and the OxC-beta product line for use in human and animal applications.Confidence. The toxicology test allows Avivagen to reinforce the safeness of OxC-beta through providing more formal evidence in support of regulatory approval and additional adoption in jurisdictions and applications. We believe the studies show confidence in the OxC-beta line and with the positive toxicology results, the Company adds another feather to its cap in marketing the feed additive to other countries for expansion. Read More >>